Structures of the activator of k. pneumonia biofilm formation, mrkh, indicates pilz domains involved in c-di-gmp and DNA binding

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 36, 2016, Pages 10067-10072

  Schumachera, Maria A ^a   Zenga, Wenjie ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Binding motif|pilz |klebsiella pneumonia; Biofilm

Indexed keywords

3',5' CYCLIC DIGUANYLIC ACID; BACTERIAL PROTEIN; CYCLIC GMP; MANNOSE RESISTANT KLEBSIELLA LIKE HEMAGGLUTININ; MONOMER; PROTEIN; PROTEIN PILZ; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BACTERIAL DNA; BIS(3',5')-CYCLIC DIGUANYLIC ACID; PROTEIN BINDING; RECOMBINANT PROTEIN;

BIOFILM; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONFERENCE PAPER; DNA BINDING; GENE EXPRESSION; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; ALPHA HELIX; ANALOGS AND DERIVATIVES; BETA SHEET; BINDING SITE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOLECULAR CLONING; MOLECULAR MODEL; PATHOGENICITY; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN MOTIF; X RAY CRYSTALLOGRAPHY;

AMINO ACID MOTIFS; BACTERIAL PROTEINS; BINDING SITES; BIOFILMS; CLONING, MOLECULAR; CRYSTALLOGRAPHY, X-RAY; CYCLIC GMP; DNA, BACTERIAL; GENE EXPRESSION; GENE EXPRESSION REGULATION, BACTERIAL; KLEBSIELLA PNEUMONIAE; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION, ALPHA-HELICAL; PROTEIN CONFORMATION, BETA-STRAND; PROTEIN FOLDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS;

EID: 84986218159     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1607503113     Document Type: Article

References (34)

1. Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11(4): 589-603.
2. Fernandes A, Dias M (2013) The microbiological profiles of infected prosthetic implants with an emphasis on the organisms which form biofilms. J Clin Diagn Res 7(2): 219-223.
3. Murphy CN, Mortensen MS, Krogfelt KA, Clegg S (2013) Role of Klebsiella pneumoniae type 1 and type 3 fimbriae in colonizing silicone tubes implanted into the bladders of mice as a model of catheter-associated urinary tract infections. Infect Immun 81(8):3009-3017.
4. Stahlhut SG, Struve C, Krogfelt KA, Reisner A (2012) Biofilm formation of Klebsiella pneumoniae on urethral catheters requires either type 1 or type 3 fimbriae. FEMS Immunol Med Microbiol 65(2):350-359.
5. Johnson JG, Murphy CN, Sippy J, Johnson TJ, Clegg S (2011) Type 3 fimbriae and biofilm formation are regulated by the transcriptional regulators MrkHI in Klebsiella pneumoniae. J Bacteriol 193(14):3453-3460.
6. Tan JW, et al. (2015) Positive autoregulation of mrkHI by the cyclic di-GMP-dependent MrkH protein in the biofilm regulatory circuit of Klebsiella pneumoniae. J Bacteriol 197(9):1659-1667.
7. Wilksch JJ, et al. (2011) MrkH, a novel c-di-GMP-dependent transcriptional activator, controls Klebsiella pneumoniae biofilm formation by regulating type 3 fimbriae expression. PLoS Pathog 7(8):e1002204.
8. Yang J, et al. (2013) Transcriptional activation of the mrkA promoter of the Klebsiella pneumoniae type 3 fimbrial operon by the c-di-GMP-dependent MrkH protein. PLoS One 8(11):e79038.
9. Wu CC, et al. (2012) Fur-dependent MrkHI regulation of type 3 fimbriae in Klebsiella pneumoniae CG43. Microbiology 158(Pt 4):1045-1056.
10. Di Martino P, Cafferini N, Joly B, Darfeuille-Michaud A (2003) Klebsiella pneumoniae type 3 pili facilitate adherence and biofilm formation on abiotic surfaces. Res Microbiol 154(1):9-16.
11. Sebghati TA, Korhonen TK, Hornick DB, Clegg S (1998) Characterization of the type 3 fimbrial adhesins of Klebsiella strains. Infect Immun 66(6):2887-2894.
12. Tarkkanen AM, Virkola R, Clegg S, Korhonen TK (1997) Binding of the type 3 fimbriae of Klebsiella pneumoniae to human endothelial and urinary bladder cells. Infect Immun 65(4):1546-1549.
13. Murphy CN, Clegg S (2012) Klebsiella pneumoniae and type 3 fimbriae: Nosocomial infection, regulation and biofilm formation. Future Microbiol 7(8):991-1002.
14. Jagnow J, Clegg S (2003) Klebsiella pneumoniae MrkD-mediated biofilm formation on extracellular matrix- and collagen-coated surfaces. Microbiology 149(pt 9): 2397-2405.
15. Römling U, Galperin MY, Gomelsky M (2013) Cyclic di-GMP: The first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev 77(1):1-52.
16. Sondermann H, Shikuma NJ, Yildiz FH (2012) You've come a long way: c-di-GMP signaling. Curr Opin Microbiol 15(2):140-146.
17. Hengge R (2009) Principles of c-di-GMP signalling in bacteria. Nat Rev Microbiol 7(4): 263-273.
18. Tschowri N, et al. (2014) Tetrameric c-di-GMP mediates effective transcription factor dimerization to control Streptomyces development. Cell 158(5):1136-1147.
19. Amikam D, Galperin MY (2006) PilZ domain is part of the bacterial c-di-GMP binding protein. Bioinformatics 22(1):3-6.
20. Ryan RP, Tolker-Nielsen T, Dow JM (2012) When the PilZ don't work: Effectors for cyclic di-GMP action in bacteria. Trends Microbiol 20(5):235-242.
21. Alm RA, Bodero AJ, Free PD, Mattick JS (1996) Identification of a novel gene, pilZ, essential for type 4 fimbrial biogenesis in Pseudomonas aeruginosa. J Bacteriol 178(1): 46-53.
22. Benach J, et al. (2007) The structural basis of cyclic diguanylate signal transduction by PilZ domains. EMBO J 26(24):5153-5166.
23. Ko J, et al. (2010) Structure of PP4397 reveals the molecular basis for different c-di-GMP binding modes by Pilz domain proteins. J Mol Biol 398(1):97-110.
24. Fujiwara T, et al. (2013) The c-di-GMP recognition mechanism of the PilZ domain of bacterial cellulose synthase subunit A. Biochem Biophys Res Commun 431(4):802-807.
25. Habazettl J, Allan MG, Jenal U, Grzesiek S (2011) Solution structure of the PilZ domain protein PA4608 complex with cyclic di-GMP identifies charge clustering as molecular readout. J Biol Chem 286(16):14304-14314.
26. Whitney JC, et al. (2015) Dimeric c-di-GMP is required for post-translational regulation of alginate production in Pseudomonas aeruginosa. J Biol Chem 290(20): 12451-12462.
27. Krasteva PV, et al. (2010) Vibrio cholerae VpsT regulates matrix production and motility by directly sensing cyclic di-GMP. Science 327(5967):866-868.
28. Li W, He ZG (2012) LtmA, a novel cyclic di-GMP-responsive activator, broadly regulates the expression of lipid transport and metabolism genes in Mycobacterium smegmatis. Nucleic Acids Res 40(22):11292-11307.
29. Fazli M, et al. (2011) The CRP/FNR family protein Bcam1349 is a c-di-GMP effector that regulates biofilm formation in the respiratory pathogen Burkholderia cenocepacia. Mol Microbiol 82(2):327-341.
30. Leduc JL, Roberts GP (2009) Cyclic di-GMP allosterically inhibits the CRP-like protein (Clp) of Xanthomonas axonopodis pv. citri. J Bacteriol 191(22):7121-7122.
31. Chin KH, et al. (2010) The cAMP receptor-like protein CLP is a novel c-di-GMP receptor linking cell-cell signaling to virulence gene expression in Xanthomonas campestris. J Mol Biol 396(3):646-662.
32. Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372(3):774-797.
33. Adams PD, et al. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66(pt 2):213-221.
34. Chen VB, et al. (2010) MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66(pt 1):12-21.